Dr. Michael Stacey received his PhD from the University of Birmingham, England, working on cancer-predisposing syndromes. He completed a fellowship in Clinical Genetics at Birmingham, working on the ICF syndrome, before moving to the University of Oxford, England as a post doc to work on drug metabolizing genes in bladder cancer. After moving to the USA, Dept. of Pediatrics, Eastern Virginia Medical School, he continued work as an Assistant Professor on drug-metabolizing genes, now in patients predisposed to blood cancer. It was here that he was introduced to the field of bioelectrics and eventually joined the Center for Bioelectrics at Old Dominion University in 2007 as an Associate Research Professor. Initially working on the bioelectrical properties of cartilage, receiving an R21 from the NIH (NIAMS), he has continued cancer research, combining his cancer and cartilage background to study cartilage-forming tumors, the chondrosarcomas.
Dr. Michael Stacey received his PhD from the University of Birmingham, England, working on cancer-predisposing syndromes. He completed a fellowship in Clinical Genetics at Birmingham, working on the ICF syndrome, before moving to the University of Oxford, England as a post doc to work on drug metabolizing genes in bladder cancer. After moving to the USA, Dept. of Pediatrics, Eastern Virginia Medical School, he continued work as an Assistant Professor on drug-metabolizing genes, now in patients predisposed to blood cancer. It was here that he was introduced to the field of bioelectrics and eventually joined the Center for Bioelectrics at Old Dominion University in 2007 as an Associate Research Professor. Initially working on the bioelectrical properties of cartilage, receiving an R21 from the NIH (NIAMS), he has continued cancer research, combining his cancer and cartilage background to study cartilage-forming tumors, the chondrosarcomas.